In CRC cells, MYC-mediated glycolysis is mainly affected by IGF2BP2’s downstream effects, which are attenuated when LINRIS is knocked down (Wang et al., 2019b). This evidence concerns the gene IGF2BP2 and colorectal carcinoma.